back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-09 16:34 Tx date 2023-06-06 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+30,000 vol |
60,000 | |
| Filed 2023-06-09 16:32 Tx date 2023-06-06 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-30,000 vol |
0 | |
| Filed 2022-12-02 20:08 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+30,000 vol |
30,000 | |
| Filed 2022-12-02 20:06 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-30,000 vol |
30,000 | |
| Filed 2022-11-30 15:31 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 18:18 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-195,600
-60,000 vol $3.26 each |
60,000 | |
| Filed 2022-10-05 18:17 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$84,600
+60,000 vol $1.41 each |
60,000 | |
| Filed 2022-10-05 18:15 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-29 18:42 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 |